Newbridge Financial Services Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.29K Hold
17
﹤0.01% 934
2025
Q4
$4.7K Hold
17
﹤0.01% 908
2025
Q3
$4.48K Sell
17
-28
-62% -$6.8K ﹤0.01% 1037
2025
Q2
$9.86K Sell
45
-450
-91% -$96.2K ﹤0.01% 891
2025
Q1
$111K Buy
495
+450
+1,000% +$124K 0.03% 252
2024
Q4
$14.7K Buy
+45
New +$14.2K ﹤0.01% 668
2024
Q3
Sell
-45
Closed -$14.8K 1129
2024
Q2
$14.8K Buy
45
+17
+61% +$6.01K 0.01% 632
2024
Q1
$11.1K Hold
28
﹤0.01% 743
2023
Q4
$9.86K Hold
28
﹤0.01% 739
2023
Q3
$10.5K Hold
28
0.01% 810
2023
Q2
$10.7K Hold
28
0.01% 873
2023
Q1
$9.7K Buy
+28
New +$8.18K 0.01% 919
2021
Q3
Sell
-12
Closed -$4K 1628
2021
Q2
$4K Hold
12
﹤0.01% 1184
2021
Q1
$3K Hold
12
﹤0.01% 1137
2020
Q4
$3K Sell
12
-36
-75% -$10.1K ﹤0.01% 938
2020
Q3
$13K Buy
+48
New +$12.7K 0.01% 619

Other funds holding WST